KRAS and familial pancreatic carcinoma: The decades of intensity with which drugging KRAS has been pursued, which include unconventional measures such as trying to understand how KRAS folds in microgravity on the International Space Station (87), underscore the potential clinical impact of a successful direct KRAS-targeted therapeutic strategy relevant for pancreatic cancer patients.